Incyte Holdings Corporation & Ors. v.Macleods Pharmaceuticals Ltd
Delhi High Court - Orders · CS(COMM) 763/2026
The plaintiffs, Incyte Holdings Corporation and others, filed a patent infringement suit against Macleods Pharmaceuticals Ltd. concerning Indian Patent No. 269841 (IN'841), which protects the novel compound Ruxolitinib used in treating myelofibrosis. The plaintiffs alleged that the defendant intended to commercially launch Ruxolitinib-based products, which would infringe Claims 1, 17, and 21 of IN'841. The defendant undertook not to commercially manufacture, launch, import, export, or deal in any product containing Ruxolitinib during the patent's validity, and the suit was disposed of based on this undertaking, while preserving the defendant's rights under Section 107A of the Patents Act, 1970 for research use.